Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission

被引:0
作者
Lise Boey
Mathieu Roelants
Joanna Merckx
Niel Hens
Isabelle Desombere
Els Duysburgh
Corinne Vandermeulen
机构
[1] Leuven University Vaccinology Center,Environment and Health, Department of Public Health and Primary Care
[2] KU Leuven,Department of Epidemiology, Biostatistics and Occupational Health
[3] McGill University,Data Science Institute
[4] I-BioStat,Modelling Infectious Diseases, Vaccine and Infectious Disease Institute
[5] Hasselt University,Epidemiology and Public Health
[6] Centre for Health Economic Research,undefined
[7] University of Antwerp,undefined
[8] Infectious Diseases in Humans,undefined
[9] Sciensano (Public Health Belgium),undefined
[10] Sciensano (Public Health Belgium),undefined
来源
European Journal of Pediatrics | 2022年 / 181卷
关键词
COVID-19; SARS-CoV-2; Serosurvey; Seroprevalence; Schoolchildren; Adolescents;
D O I
暂无
中图分类号
学科分类号
摘要
It is not yet clear to what extent SARS-CoV-2 infection rates in children reflect community transmission, nor whether infection rates differ between primary schoolchildren and young teenagers. A cross-sectional serosurvey compared the SARS-CoV2 attack-rate in a sample of 362 children recruited from September 21 to October 6, 2020, in primary (ages 6–12) or lower secondary school (ages 12–15) in a municipality with low community transmission (Pelt) to a municipality with high community transmission (Alken) in Belgium. Children were equally distributed over grades and regions. Blood samples were tested for the presence of antibodies to SARS-CoV-2 with an enzyme-linked immunosorbent assay. We found anti-SARS-CoV-2 antibodies in 4.4% of children in the low transmission region and in 14.4% of children in the high transmission region. None of the primary schoolchildren were seropositive in the low transmission region, whereas the seroprevalence among primary and secondary schoolchildren did not differ significantly in the high transmission region. None of the seropositive children suffered from severe disease. Children who were in contact with a confirmed case (RR 2.9; 95%CI 1.6–4.5), who participated in extracurricular activities (RR 5.6; 95%CI 1.2–25.3), or whose caregiver is a healthcare worker who had contact with COVID-19 patients (RR 2.2; 95%CI 1.0–4.6) were at higher risk of seropositivity. If SARS-CoV2 circulation in the community is high, this will be reflected in the pediatric population with similar infection rates in children aged 6–12 years and 12–15 years.
引用
收藏
页码:571 / 578
页数:7
相关论文
共 30 条
  • [1] Havers FP(2020)Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020 JAMA Intern Med 396 535-544
  • [2] Reed C(2020)Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Lancet 396 313-319
  • [3] Lim T(2020)Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study Lancet 370 2516-2034
  • [4] Pollán M(2020)Diagnostic accuracy of serological tests for covid-19: Systematic review and meta-analysis BMJ 71 2027-1734
  • [5] Pérez-Gómez B(2020)Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019 Clin Infect Dis 383 1724-undefined
  • [6] Pastor-Barriuso R(2020)Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care Clin Infect Dis undefined undefined-undefined
  • [7] Stringhini S(2020)Public health antibody screening indicates a six-fold higher SARS-CoV-2 exposure rate than reported cases in children Med undefined undefined-undefined
  • [8] Wisniak A(2020)SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England Lancet Infect Dis undefined undefined-undefined
  • [9] Piumatti G(2020)Humoral immune response to SARS-CoV-2 in Iceland N Engl J Med undefined undefined-undefined
  • [10] Lisboa Bastos M(2020)Severe acute respiratory syndrome coronavirus 2 antibody prevalence in blood in a large school community subject to a coronavirus disease 2019 outbreak: a cross-sectional study Clin Infect Dis undefined undefined-undefined